Comprehensive Tobacco Cessation Implementation for Oregon Pharmacists

Comprehensive Tobacco Cessation Implementation:

Through June 30, 2025, Oregon pharmacists can receive free access to this course provided by the Oregon Health Authority. To receive free access, email your OR RPh license # and employer to PharmacyCE@oregonstate.edu.

In Oregon, more than 6 out of 10 people who smoke cigarettes want to quit. Most people who smoke have attempted to quit in the past year. Smoking is the leading cause of death and disease in Oregon, killing 8,000 people every year.

The course is uniquely designed to educate the Oregon pharmacist on assessing and prescribing tobacco cessation medications

The Oregon Health Authority- Public Health Division (OHA-PHD) and the Health Promotion and Chronic Disease Prevention Section (HPCDP) collaborated with the Oregon State University of Pharmacy to train pharmacists to treat nicotine addiction.

Accreditation Council for Pharmacy Education Information:

This program has been planned and implemented in accordance with the policies of the Accreditation Council for Pharmacy Education through the sponsorship of OSU College of Pharmacy. The OSU College of Pharmacy is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Upon completion of this activity, participants will receive a Statement of Completion, and a Statement of Credit shall be uploaded to CPE Monitor. Completion requires 1) Registration for the course 2) Completion of all modules 3) Passing a final exam with 80% or higher and 4) Completion of the program evaluation.

At the completion of this activity, the participant will be able to:
1) Discuss the epidemiology and burden of tobacco use
2) Compare the different types of tobacco products and electronic nicotine delivery systems (ENDS) people use, and how they are often used together
3) List the different FDA approved medications to help with tobacco cessation
4) Describe possible side effects of FDA-approved medications for tobacco cessation
5) Counsel patients on how to use FDA-approved medications for tobacco cessation
6) Apply the 5As approach during a pharmacist-provided tobacco cessation visit
7) Analyze and discuss the questions on the "Tobacco Cessation Self-Screening Patient Intake Form"
8) Apply the patient care process utilizing the "Tobacco Cessation Assessment and Treatment Care Pathway"
9) List the elements in a tobacco cessation follow up, per Oregon's requirements
10) Document a tobacco cessation visit, per Oregon's assessment and prescribing requirements
11) List and discuss five resources recommended for assisting Oregon patients attempting to quit smoking
12) Describe the billing guidelines for the pharmacist-led patient assessment

UAN: 0036-0000-24-035-H01-P
Target Audience: Pharmacists licensed in Oregon
Activity Type: Application
Activity Release Date: 10/20/2024
Activity Expiration Date: 10/20/2027
Faculty/Contributors: 
Julianne Himstreet, PharmD, BCPS, Adjunct Faculty, Oregon State University College of Pharmacy
Kiyomi Lehman, PharmD, BCPS, BCACP, Clinical Ambulatory Care Pharmacist, Mosaic Medical
Hilde Hinkel, MPH, Health Promotion Strategist, Oregon Health Authority
Sarah Hargand, MPH, Oregon Health Authority
Sarah Wylie, MPH, Health Promotion Strategist, Oregon Health Authority
Rebecca Garza, MS, Health Promotion Strategist, Oregon Health Authority
Derek Smith, MSW, MPH, Tobacco Policy Specialist, Oregon Health Authority
Paige Clark, RPh, BPharm
Sharon Rask, RPh, BPharm
Disclosures: None of the faculty, designers, or reviewers for this course have any relationships with ineligible to disclose.